Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.
Zingman
B S
BS
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D016049:Didanosine / Q000627:therapeutic use*; D015725:Fluconazole / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D011804:Quinolines / Q000627:therapeutic use*; D019258:Saquinavir
D000935:Antifungal Agents; D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D015725:Fluconazole; D016049:Didanosine; D019258:Saquinavir